Hemodialysis And Peritoneal Dialysis Global Market Report 2024

Hemodialysis and peritoneal dialysis are medical procedures used to remove waste products and excess fluids, such as urea and creatinine, from the blood by rerouting it to a machine for purification. Hemodialysis involves cleaning the blood using a dialysis machine and a specific filter called an artificial kidney or dialyzer. This type of dialysis utilizes the patient's own bodily tissues inside the abdominal cavity as a filtering mechanism.

The main types of hemodialysis and peritoneal dialysis include various modalities such as hemodialysis, short-term catheters, chronic catheters, graft, fistula, and peritoneal dialysis. Hemodialysis is a procedure where a dialysis machine and a special filter (dialyzer) are employed to clean the blood. The modality can be conventional or daily (daytime and nighttime). End-users of these dialysis methods include hospitals, clinics, dialysis centers, and individuals undergoing home dialysis.

The hemodialysis and peritoneal dialysis market research report is one of a series of new reports that provides hemodialysis and peritoneal dialysis market statistics, including hemodialysis and peritoneal dialysis industry global market size, regional shares, competitors with a hemodialysis and peritoneal dialysis market share, detailed hemodialysis and peritoneal dialysis market segments, market trends and opportunities, and any further data you may need to thrive in the hemodialysis and peritoneal dialysis industry. This hemodialysis and peritoneal dialysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemodialysis and peritoneal dialysis market size has grown strongly in recent years. It will grow from $78.64 billion in 2023 to $85.05 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth observed during the historic period can be attributed to several factors, including the increased adoption of home-based treatment for dialysis, a rise in cases of end-stage renal disease (ESRD), increased healthcare reimbursement for dialysis services, greater involvement of nephrologists in patient care, and a growing preference among patients for dialysis treatment. These factors collectively contributed to the development and expansion of dialysis services during the historical period.

The hemodialysis and peritoneal dialysis market size is expected to see strong growth in the next few years. It will grow to $119.91 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing cases of end-stage renal disease (ESRD), the rising implementation of remote monitoring, the expansion of telehealth services, the increase in automated peritoneal dialysis, and the growing focus on patient-centered care. Major trends expected during this period include the emergence of wearable dialysis devices, the integration of data analytics and artificial intelligence (AI) in dialysis management, a heightened focus on water quality management, the development of innovative dialysis machines, and the adoption of personalized dialysis regimens. These trends reflect a shift towards more advanced and patient-centric approaches in the field of dialysis.

The anticipated growth of the hemodialysis and peritoneal dialysis market is driven by the increasing prevalence of kidney diseases. Kidney disorders represent a diverse group of conditions impacting the structure and function of the kidneys. Advanced chronic renal disease can lead to dangerously high levels of fluid, electrolytes, and wastes in the body. Hemodialysis and peritoneal dialysis are vital treatment modalities wherein the blood is cleansed using a dialysis machine and a specific filter known as an artificial kidney. According to the Centers for Disease Control and Prevention's 2021 report on chronic kidney disease, approximately 15% of US adults, or 37 million people, are estimated to have chronic kidney diseases. This substantial prevalence of kidney diseases is a significant driver for the growth of the hemodialysis and peritoneal dialysis market.

The rising prevalence of hypertension is poised to further propel the growth of the hemodialysis and peritoneal dialysis market. Hypertension, characterized by consistently high blood pressure, is a medical condition with long-term implications. Hemodialysis and peritoneal dialysis play a crucial role in managing hypertension by regulating fluid balance, eliminating soluble toxins, and maintaining proper electrolyte balance. According to the Centers for Disease Control and Prevention (CDC), hypertension accounted for 691,095 fatalities in the US in 2021. The increasing prevalence of hypertension underscores the importance of hemodialysis and peritoneal dialysis as effective interventions, driving market growth.

Technological advancements represent a prominent trend in the hemodialysis and peritoneal dialysis market, with major companies focusing on innovative solutions to strengthen their market positions. In April 2022, Kuleana Technology, Inc., a Seattle-based startup, secured the first dialysis funding from the National Kidney Foundation (NKF) Innovation Fund. Kuleana is developing revolutionary portable hemodialysis equipment that doesn't require connection to an external water supply and avoids the need for complicated sorbents. This portable device enables efficient dialysis on the go, offering a more flexible solution compared to existing dialysis methods. This innovation aligns with the broader trend of leveraging technology to enhance renal replacement therapies and make dialysis more accessible for millions of patients globally, contributing to the growth of the hemodialysis and peritoneal dialysis market.

Prominent companies in the hemodialysis and peritoneal dialysis market are strategically focusing on innovative technologies, such as versi HD with guideme software, to drive revenues and bring about advancements in chronic home hemodialysis (HHD) systems. This innovative technology is designed to enhance the lives of both patients and healthcare professionals, marking a significant development in the field. As an example, in September 2023, Fresenius Medical Care AG and Co. KGaA, a leading Germany-based healthcare group specializing in kidney care, introduced the new versi HD with guideme software. This cutting-edge technology features a touchscreen interface, providing a user-friendly and streamlined experience for HHD. The introduction of versi HD with guideme software is aimed at increasing the accessibility of home therapy for more patients. By offering a touchscreen interface, Fresenius Medical Care aims to make HHD more convenient and user-friendly, encouraging a greater number of individuals with renal failure to choose life-sustaining care in the comfort of their own homes. This extension is a crucial step in expanding the options for people requiring renal care, promoting the adoption of home-based therapies.

In March 2021, DaVita Kidney Care, a US-based company specializing in the treatment of patients with chronic kidney failure and end-stage kidney disease, entered into a collaborative extension with Fresenius Medical Care. This strategic partnership enables DaVita to provide its patients across the United States with access to home hemodialysis technology, including NxStage machines, necessary supplies, and a connected health platform. The collaboration aligns with the shared objectives of both companies to promote the adoption of home dialysis, enhancing the quality of life for individuals dealing with chronic kidney failure. Fresenius Medical Care, also a US-based company specializing in kidney care, actively contributes to the success of this joint initiative.

Major companies operating in the hemodialysis and peritoneal dialysis market include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., Nipro Corporation, B. Braun Melsungen AG, Nikkiso Co. Ltd., DaVita Inc., Asahi Kasei Corporation, Medtronic PLC, AngioDynamics Inc., Becton, Dickinson and Company, Rockwell Medical Inc., Cantel Medical Corp., NxStage Medical Inc., Quanta Dialysis Technologies Ltd., Outset Medical Inc., Medivators Inc., Medisystems Corporation, Allmed Medical Products Co. Ltd., Jiangsu Lengthen Life Science and Technology Co. Ltd., Toray Medical Co. Ltd., Medcomp, Medline Industries Inc., Atlantic Medical Supply Co. Inc., Dialife Group, Diaverum, Satellite Healthcare Inc., U.S. Renal Care Inc., American Renal Associates Holdings Inc., Rogosin Institute, Northwest Kidney Centers

North America was the largest region in the hemodialysis and peritoneal dialysis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemodialysis and peritoneal dialysis market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the hemodialysis and peritoneal dialysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The hemodialysis and peritoneal dialysis market includes revenues earned by entities by n-center hemodialysis, home hemodialysis, and peritoneal dialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.